BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 11, 2005
View Archived Issues
Dosing begins in first phase I study for obesity compound oleoyl estrone
Read More
Benitec and Garven Institute to develop drugs for diabetes and obesity
Read More
Yamanouchi and Nippon Kayaku sign license agreement for Gelpart
Read More
Further studies planned to investigate Alferon N for avian flu
Read More
First patient treated in acute spinal cord injury study of Cethrin
Read More
A phase II study shows effective glycemic control with Basulin in type 1 diabetes
Read More
Update on the pharmacokinetics and safety of Virulizin in pancreatic cancer
Read More
Higher plasma ghrelin levels found in schizophrenics after olanzapine therapy
Read More
New River reviews pipeline progress
Read More
Recent progress at Migenix
Read More
Phase I/II study to evaluate Onconase in refractory NSCLC
Read More
Quark Biotech licenses BT-16 to Sanwa Kagaku Kenkyusho
Read More
Enrollment under way in confirmatory phase IIb study of DP-b99 in acute stroke
Read More
NovaDel initiates pilot study of lingual spray formulation of ondansetron
Read More
Medtronic and Alnylam to develop treatments for neurodegenerative disorders
Read More
IND approval allows initiation of phase I trials for PGX-100
Read More
Melatonin analogue ML-23 reverses experimental Parkinson's disease in marmosets
Read More
Irbesartan plus lipoic acid improves endothelial function of patients with metabolic syndrome
Read More
SSR-149415 exerts antidepressant-like effects through vasopressin V1b receptors in lateral septum
Read More
Antitumor indenoindole derivative S-36888 cures mice with C38 colon adenocarcinoma
Read More
First data on the efficacy of androgen antagonists in bulimia nervosa
Read More
Role for the NO-NSAID HCT-1026 in the control of microglia activation
Read More
Beth Israel claims imatinib mesylate/rapamycin combination for vascular stenosis and restenosis
Read More
Novel anticoagulant agents discovered at Lilly
Read More
New tyrosine kinase inhibitors identified at Boehringer Ingelheim
Read More
Abbott presents new dopamine D3 modulators for schizophrenia
Read More
Novel protein tyrosine kinase inhibitors and their use as anticancer agents
Read More
Anti-CD3 monoclonal antibodies with reduced immunogenicity claimed by Alexion
Read More
Novel PARP-1 inhibitors described by Altana Pharma in recent patent
Read More